North America Iliac Stent Market Size, Share & Trends Analysis Report By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By End-use, By Country and Growth Forecast, 2023 - 2030
The North America Iliac Stent Market would witness market growth of 5.3% CAGR during the forecast period (2023-2030).
The US market dominated the North America Others Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $38.7 million by 2030. The Canada market is experiencing a CAGR of 10.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.8% during (2023 - 2030).
Iliac stent procedures stand at the forefront of innovation, revolutionizing the treatment landscape for patients with the disease. The adoption trends in the market reflect a dynamic interplay of technological innovation, clinical evidence, regulatory considerations, and healthcare economics, shaping patterns of utilization and market dynamics.
Next-generation stent platforms offer improved radial strength, flexibility, and conformability, allowing for precise placement and optimal lesion coverage in challenging anatomies. Moreover, innovations in drug-eluting stents, bioresorbable stents, and surface-modified coatings aim to enhance patency rates, reduce restenosis, and improve long-term outcomes, driving the adoption of advanced stent technologies.
Canada has a high rate of vehicular accidents, which has raised demand for medical procedures such as the implantation of iliac stents to treat vascular problems and traumatic injuries. According to the Canadian government, in 2021, motor vehicle fatalities totalled 1,768, representing an increase of 1.3% compared to the 2020 figure of 1,746. Additionally, serious injuries from motor vehicle accidents rose by 4% to 8,185, while the total number of injuries increased by 3.6% to 1,08,018. Therefore, the increasing road traffic injuries and rapid urbanization in the region propel the market’s growth.
Based on Artery Lesions, the market is segmented into Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. Based on End-use, the market is segmented into Hospitals, Outpatient Facilities, and Others. Based on Type, the market is segmented into Self-expandable Stents, Balloon-expandable Stents, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Becton, Dickinson and Company
- Abbott Laboratories
- Boston Scientific Corporation
- W. L. Gore & Associates, Inc.
- Medtronic PLC
- Cook Medical, Inc.(Cook Group)
- Terumo Corporation
- iVascular S.L.U.
- Getinge AB
- Biotronik SE & Co. KG
By Artery Lesions
- Common Iliac Artery Lesions
- Severe Calcified Lesions
- Complete Obstructive Lesions
- Hospitals
- Outpatient Facilities
- Others
- Self-expandable Stents
- Balloon-expandable Stents
- Others
- US
- Canada
- Mexico
- Rest of North America
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Iliac Stent Market, by Artery Lesions
- 1.4.2 North America Iliac Stent Market, by End-use
- 1.4.3 North America Iliac Stent Market, by Type
- 1.4.4 North America Iliac Stent Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Opportunities
- 3.2.3 Market Restraints
- 3.2.4 Market Challenges
- 3.3 Porter’s Five Forces Analysis
- Chapter 4. North America Iliac Stent Market by Artery Lesions
- 4.1 North America Common Iliac Artery Lesions Market by Country
- 4.2 North America Severe Calcified Lesions Market by Country
- 4.3 North America Complete Obstructive Lesions Market by Country
- Chapter 5. North America Iliac Stent Market by End-use
- 5.1 North America Hospitals Market by Country
- 5.2 North America Outpatient Facilities Market by Country
- 5.3 North America Others Market by Country
- Chapter 6. North America Iliac Stent Market by Type
- 6.1 North America Self-expandable Stents Market by Country
- 6.2 North America Balloon-expandable Stents Market by Country
- 6.3 North America Others Market by Country
- Chapter 7. North America Iliac Stent Market by Country
- 7.1 US Iliac Stent Market
- 7.1.1 US Iliac Stent Market by Artery Lesions
- 7.1.2 US Iliac Stent Market by End-use
- 7.1.3 US Iliac Stent Market by Type
- 7.2 Canada Iliac Stent Market
- 7.2.1 Canada Iliac Stent Market by Artery Lesions
- 7.2.2 Canada Iliac Stent Market by End-use
- 7.2.3 Canada Iliac Stent Market by Type
- 7.3 Mexico Iliac Stent Market
- 7.3.1 Mexico Iliac Stent Market by Artery Lesions
- 7.3.2 Mexico Iliac Stent Market by End-use
- 7.3.3 Mexico Iliac Stent Market by Type
- 7.4 Rest of North America Iliac Stent Market
- 7.4.1 Rest of North America Iliac Stent Market by Artery Lesions
- 7.4.2 Rest of North America Iliac Stent Market by End-use
- 7.4.3 Rest of North America Iliac Stent Market by Type
- Chapter 8. Company Profiles
- 8.1 Becton, Dickinson, and Company
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 Recent strategies and developments:
- 8.1.5.1 Trials and Approvals:
- 8.1.6 SWOT Analysis
- 8.2 Abbott Laboratories
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
- 8.3 Boston Scientific Corporation
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
- 8.3.5.1 Trials and Approvals:
- 8.3.6 SWOT Analysis
- 8.4 W. L. Gore & Associates, Inc.
- 8.4.1 Company Overview
- 8.4.2 SWOT Analysis
- 8.5 Medtronic PLC
- 8.5.1 Company overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
- 8.5.5.1 Trials and Approvals:
- 8.5.6 SWOT Analysis
- 8.6 Cook Medical, Inc. (Cook Group)
- 8.6.1 Company Overview
- 8.6.2 SWOT Analysis
- 8.7 Terumo Corporation
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 Recent strategies and developments:
- 8.7.5.1 Trials and Approvals:
- 8.7.5.2 Product Launches and Product Expansions:
- 8.7.6 SWOT Analysis
- 8.8 iVascular S.L.U.
- 8.8.1 Company Overview
- 8.8.2 SWOT Analysis
- 8.9 Getinge AB
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 Recent strategies and developments:
- 8.9.5.1 Trials and Approvals:
- 8.9.6 SWOT Analysis
- 8.10. Biotronik SE & Co. KG
- 8.10.1 Company Overview
- 8.10.2 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook